Trial Profile
Safety and efficacy of in patients with rheumatoid arthritis: A real-life cohort study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 28 Aug 2016
Price :
$35
*
At a glance
- Drugs Tocilizumab (Primary) ; Tocilizumab (Primary)
- Indications Rheumatoid arthritis
- Focus Adverse reactions; Therapeutic Use
- 28 Aug 2016 New trial record